Please assess the completion status of the following clinical trial:

Trial Title: Presyncope (Syncope) Prevention Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 10 years through 14 years of age~2. The subject must be receiving at least one vaccine delivered intramuscularly~3. The parent/guardian must be willing and capable of providing written informed consent for the adolescent and the adolescent must be willing and capable of providing assent.~4. The subject must be willing to stay for the completion of all study-related activities.~5. Parent/guardian and adolescent must speak and read English by self-report~6. Parent/guardian must be willing to let their child select an electronic game to play during the study~Exclusion Criteria:~1. Receipt of investigational or experimental vaccine or medication within the previous two weeks~2. Receipt of routine injectable medication~3. Permanent indwelling venous catheter~4. Blood drawn within the past hour or scheduled for a blood draw during the post-vaccination observation period~5. Injection of medication during the past hour or scheduled for injection of medication during the observation period.~6. Cold intolerance or cold urticaria~7. Raynaud's phenomenon~8. Sickle cell disease~9. Significant visual impairment or blindness~10. Significant auditory impairment or deafness~11. Febrile (\>38.0°C) or acutely ill individuals~12. Upper arm or shoulder pain or injury~13. Video game-induced seizures~14. Adolescent or parent/Guardian is an immediate relative of study staff or an employee who is supervised by study staff.~15. Any condition that would, in the opinion of the site investigator, place the participant at an unacceptable risk of injury or render the participant unable to meet the requirements of the protocol

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 14 Years
- Healthy Volunteers: t

Study Arms:
- Usual Care (Type: NO_INTERVENTION): Participants received usual care that followed administration of a vaccine and a 20 minute post vaccination observation period.
- Buzzy ® and Electronic Game (Type: EXPERIMENTAL): Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then played that game for a specified amount of time before, during and after the vaccination administration.

Based on this trial design, predict the completion outcome and termination type (if applicable).